PDS Planning’s Idexx Laboratories IDXX Stock Holding History

PDS Planning’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$528K	Hold	1,003	–	–	0.03%	286
2026 Q1	$564K	Buy	1,003 +42	+4%	+$26.9K	0.04%	242
2025 Q4	$650K	Sell	961 -6	-0.6%	-$4.09K	0.04%	209
2025 Q3	$618K	Sell	967 -10	-1%	-$6.07K	0.04%	206
2025 Q2	$524K	Buy	977 +336	+52%	+$161K	0.04%	226
2025 Q1	$269K	Buy	641 +24	+4%	+$10.4K	0.02%	350
2024 Q4	$255K	Buy	617 +14	+2%	+$6.14K	0.02%	336
2024 Q3	$305K	Buy	603 +15	+3%	+$7.29K	0.03%	291
2024 Q2	$286K	Sell	588 -1	-0.2%	-$502	0.03%	265
2024 Q1	$318K	Buy	589 +8	+1%	+$4.37K	0.03%	246
2023 Q4	$322K	Buy	581 +26	+5%	+$12.2K	0.04%	222
2023 Q3	$243K	Sell	555 -27	-5%	-$13.5K	0.03%	249
2023 Q2	$292K	Buy	582 +171	+42%	+$81.9K	0.04%	221
2023 Q1	$206K	Buy	+411	New	+$197K	0.03%	262

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

PDS Planning's IDXX Position: Q2 2026 in Review

PDS Planning held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1,003 shares worth $528K. The position accounts for 0.03% of the portfolio, ranked #286.

PDS Planning first reported a position in IDXX in Q1 2023 and has held it in 14 quarters since. The position peaked at $650K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

PDS Planning held 1,003 shares of Idexx Laboratories worth $528K as of Q2 2026.
PDS Planning left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.03% of PDS Planning's portfolio in Q2 2026, its #286 holding.
PDS Planning first reported a position in Idexx Laboratories in Q1 2023 and has held it in 14 quarters since.
PDS Planning's Idexx Laboratories position peaked at $650K in Q4 2025.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on PDS Planning's 13F filing for Q2 2026, filed 5 Aug 2026.